Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5770279 | 0.91 | MAPT (0.58) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL9688979 | 0.91 | MAPT (0.58) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL30394931 | 0.91 | MAPT (0.58) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL1867644 | 0.87 | SNCA (0.56) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL9121535 | 0.87 | PKM (0.50) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL9121538 | 0.87 | PKM (0.50) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL2897838 | 0.86 | PKM (0.45) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL8630136 | 0.85 | HTR1A (0.59) | MAPTKMT2AGAATDP1KDM4E | |
| SCHEMBL28630446 | 0.85 | PKM (0.59) | PKMPTGS2PTGS1CYP3A4CYP1A2 | |
| SCHEMBL9125332 | 0.85 | MEN1 (0.53) | PKMPTGS2PTGS1CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2847784-B1 | POLISHING PAD WITH LIGHT-STABLE LIGHT-TRANSMITTING REGION | CABOT MICROELECTRONICS CORP (US) | 2017-07-05 | — | — | EP | claimed |
| EP-1871735-B1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2015-12-23 | — | — | EP | claimed |
| EP-1747773-B1 | Photostable organic sunscreen compositions with antioxidant properties | MERCK PATENT GMBH (DE) | 2010-08-04 | — | — | EP | claimed |
| EP-1848507-B1 | PREPARATION CONTAINING NANOPARTICULATE UV PROTECTION AGENTS | MERCK PATENT GMBH (DE) | 2009-08-05 | — | — | EP | claimed |
| CN-1826389-A | Nanoparticulate UV protectant with silica coating | MERCK PATENT GMBH (DE) | 2006-08-30 | — | — | CN | claimed |
| CN-1798538-A | Photostable organic sunscreen composition | MERCK PATENT GMBH (DE) | 2006-07-05 | — | — | CN | claimed |
| US-20260096977-A1 | Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Flavone | L'OREAL (FR) | 2026-04-09 | — | — | US | disclosed |
| US-20260096956-A1 | NON-WHITENING MINERAL SUNSCREEN | L'OREAL (FR) | 2026-04-09 | — | — | US | disclosed |
| US-12589059-B2 | Mineral sunscreen compositions with high SPF and shelf stability | L'OREAL (FR) | 2026-03-31 | — | — | US | disclosed |
| US-20260049218-A1 | INTERFERENCE PIGMENTS | MERCK PATENT GMBH (DE) | 2026-02-19 | — | — | US | disclosed |
| EP-3592329-B1 | USE OF COMPATIBLE SOLUTES | SUSONITY Commercial GmbH (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20260034037-A1 | STABILIZED AVOBENZONE IN COSMETIC SUNSCREEN COMPOSITIONS | BEIERSDORF AG (DE) | 2026-02-05 | — | — | US | disclosed |
| US-20260034048-A1 | STABILIZATION OF AVOBENZONE IN COSMETIC SUNSCREENS | BEIERSDORF AG (DE) | 2026-02-05 | — | — | US | disclosed |
| EP-2004136-A1 | USE OF FLAVONOIDS | Merck Patent GmbH (DE) | 2008-12-24 | — | — | EP | disclosed |
| US-20080171004-A1 | Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives | MERCK PATENT GMBH (DE) | 2008-07-17 | — | — | US | disclosed |
| US-20080152603-A1 | Antioxidants | SUSONITY Commercial GmbH (DE) | 2008-06-26 | — | — | US | disclosed |
| WO-2008025368-A1 | USE OF CHROMEN-4-ONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-03-06 | — | — | WO | disclosed |
| WO-2007118565-A1 | USE OF FLAVONOIDS | MERCK PATENT GMBH (DE) | 2007-10-25 | — | — | WO | disclosed |
| CN-1826389-A | Nanoparticulate UV protectant with silica coating | MERCK PATENT GMBH (DE) | 2006-08-30 | — | — | CN | disclosed |
| CN-1798538-A | Photostable organic sunscreen composition | MERCK PATENT GMBH (DE) | 2006-07-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049218-A1 | INTERFERENCE PIGMENTS | SFN, VCL, FECH | PKM 1631/4885PTGS2 653/4885PTGS1 2331/4885 |
| US-20080152603-A1 | Antioxidants | GPX4, GPX1, CAT | PKM 1176/4885PTGS2 320/4885PTGS1 262/4885 |
| US-20260096956-A1 | NON-WHITENING MINERAL SUNSCREEN | SFN, CUTA, BRCA1 | PKM 3333/4885PTGS2 2470/4885PTGS1 2391/4885 |
| US-20260096977-A1 | Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Flavone | SOD1, TFEB, KLF5 | PKM 3126/4885PTGS2 3503/4885PTGS1 2661/4885 |
| US-20080171004-A1 | Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives | HPD, HAAO, UGT1A6 | PKM 1127/4885PTGS2 1873/4885PTGS1 1937/4885 |
| US-20260034037-A1 | STABILIZED AVOBENZONE IN COSMETIC SUNSCREEN COMPOSITIONS | TYR, RAD23B, CYP8B1 | PKM 711/4885PTGS2 4257/4885PTGS1 4538/4885 |
| US-20260034048-A1 | STABILIZATION OF AVOBENZONE IN COSMETIC SUNSCREENS | RUVBL1, CUTA, TTI1 | PKM 1605/4885PTGS2 2741/4885PTGS1 2936/4885 |
| US-12589059-B2 | Mineral sunscreen compositions with high SPF and shelf stability | CUTA, SLC39A3, SLC30A7 | PKM 2595/4885PTGS2 885/4885PTGS1 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.